NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Oct 2026 · 9 Oct 2026, 04:28 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Orchid Pharma Limited · ORCHPHARMA

✦ AI SummaryRegulatory

Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the compliances required under the regulation for the Quarter- II of Financial Year 2026-27.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

ORCHPHARMA_09102026162758_Stx_Ltr.pdf

pdf

Download →
View document text
OrchidPharm~~ -- A Dhanuka Group Company ---------------------------------- October 09, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai- 400051 Dalal Street Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Sub: Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended. Dear Sir/Madam, With reference to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended, kindly find enclosed herewith the Confirmation Certificate for the Quarter- II of Financial Year 2026-27 ended on September 30, 2026, issued by M/s. Abhipra Capital Limited, Registrar and Share Transfer Agent of Orchid Pharma Limited ("the Company"), confirming the compliances required under the above said regulation. You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited K iI yya Com any Secretary &. Compliance Officer M. No: Fl0698 Encl.; As above Co to: National Securities Depository Central Depository Services (India) Limited Limited . Trade World, 4th Floor, Kamala Mills 25th Floor, Marathon Futurex, N M Joshi I Compound, Senapati Bapat Marg, Lower Marg, Lower Parel (East), Mumbai- I Parel, Mumbai - 400013 1400013 +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. Abhipra Capital Limited (Category – I, Registrar and Transfer Agent) Abhipra Complex A-387, Dilkhush Indl Area, G.T. Karnal Road, Azadpur, Delhi-110033 Phone: +91-11-42390783 | Email: rta@abhipra.com Website: www.abhipra.com | CIN: U74899DL1994PLC061802 Ref No : RTA/REG/74(5)/ORCHID/2026/09/14 Date: 05-Oct-2026 Orchid Pharma Limited Plot Nos. 121 – 128, 128A – 133, 138 – 151, 159 – 164, Sidco Industrial Estate, Alathur, Chengalpattu District – 603110, Tamil Nadu Subject:- Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India Limited(Depositories and Participants) Regulation, 2018 for the Quarter ended 30-Sep-2026 Ref:- NSDL /CIR/II/5/2019 dated 25th January, 2019 CDSL/OPS/RTA/POLICY/2019/14 dated 25th January, 2019 SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/I dated 24/01/2019 Dear Sir, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialization during the quarter ended 30-Sep-2026 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock Exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialized have been mutilated and cancelled after due verification by the Depository participant and the name of the depositories have been substituted in register of members as the registered owner within 15 days. We request you to kindly take note of the above in your records. Thanking you, For Abhipra Capital Limited Abhinav Aggarwal (Director)